NGS has led to the identification of novel driver gene mutations in meningioma in addition to NF2, including SMO, PI3KCA, TRAF7, KLF4, AKT1, POLR2A, and SMARCE1 [7, 16–20]. The gene discussed is SMO; the disease is meningioma.